Publications by authors named "N N Katz"
Reconciling and validating the Ashworth-Davies Doppler shifts of an arbitrarily translating mirror.
J Opt Soc Am A Opt Image Sci Vis
August 2024
We simplify, to first order in , the generalized, special relativistic treatment of a Doppler shift from an arbitrarily translating mirror originally derived by Ashworth and Davies [Proc. IEEE64, 280 (1976)IEEPAD0018-921910.1109/PROC.
View Article and Find Full Text PDFQuantum computing is currently hindered by hardware noise. We present a freestyle superconducting pulse optimization method, incorporating two-qubit channels, that enhances flexibility, execution speed, and noise resilience. A minimal 0.
View Article and Find Full Text PDFArticle Synopsis
- Throughout history, Jewish individuals have made significant contributions to medicine, with many renowned physicians hailing from the Jewish community, particularly in countries like Germany before the Holocaust.
- Despite their accomplishments, Jewish doctors have historically faced prejudice, especially during the 1930s when they encountered barriers and anti-Jewish quotas that hindered their ability to practice in other countries.
- In recent times, particularly after the Hamas attack on Israel in October 2024, a resurgence of antisemitism has been observed globally, including within the healthcare sector, prompting an evaluation of these issues from the perspectives of authors in four different countries.
Objectives: Explore a newly defined composite measure of symptom progression for knee osteoarthritis (KOA) in a large, randomized study of a potential disease-modifying osteoarthritis drug (DMOAD).
Design: Using longitudinal KOA studies, a potential composite endpoint of time to symptom progression was defined as the first occurrence of worsening of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain of ≥10 points with no improvement (≤9 point decrease) in WOMAC Function (0-100 scale). A post hoc analysis explored discrimination and association with structural outcomes in the sprifermin FORWARD trial through Years 3 and 5.